A case of anaplastic large cell lymphoma, ALK positive, primary presented in the skin and relapsed with systemic involvement and leukocytosis after years of follow-up period.
Masataka
M
Hosoi
Motoshi
M
Ichikawa
Yoichi
Y
Imai
Mineo
M
Kurokawa
D000077548:Anaplastic Lymphoma Kinase; D002889:Chromosomes, Human, Pair 2 / Q000235:genetics; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics; D005260:Female; D006801:Humans; D007964:Leukocytosis / Q000097:blood / Q000628:therapy; D016246:Lymphocytes, Tumor-Infiltrating / Q000378:metabolism; D017728:Lymphoma, Large-Cell, Anaplastic / Q000097:blood / Q000235:genetics / Q000378:metabolism / Q000628:therapy; D054446:Lymphoma, Primary Cutaneous Anaplastic Large Cell / Q000235:genetics / Q000378:metabolism / Q000628:therapy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011505:Protein-Tyrosine Kinases / Q000235:genetics / Q000378:metabolism*; D020794:Receptor Protein-Tyrosine Kinases; D012878:Skin Neoplasms / Q000235:genetics / Q000378:metabolism / Q000628:therapy; D014178:Translocation, Genetic
C107023:p80(NPM-ALK) protein; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases